Associate Director - Pre-Launch Marketing and NPP at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor's degree; Post-graduate degree or MBA preferred. Business, Finance or Medical background preferred
7+ years of work experience in Brand Marketing, NPP, Medical, PRA or Finance in pharmaceutical industry
Analytics and/or forecasting experience
Deep understanding of science, coupled with a strong business acumen and analytical skills
Ability to influence stakeholders at all levels
Consistent demonstration of the leadership behaviors and ability to develop credibility in a network that spans a wide variety of functions and geographies
Strong communication skills and ability to establish effective working relationships across cultures, geographies and functions
Strong problem-solving skills; able to anticipate and recognize systemic problems, diagnose root causes and identify corrective actions that will prevent recurrence
Excellent self-management skills; able to independently manage workload, set personal priorities and adjust as needed

Responsibilities

Support the NPP leader collaborating closely with the Innovation Readiness team for the responsible TA at early stage, focusing on the responsible TA to integrate IR into dive and CD review
Conduct assessments of global portfolio assets and evaluate incoming business development deals, including providing input to early-stage opportunity assessments and long-range forecasts
Use insights from syndicated reports and desktop research to provide strategic input to the decision-making, ensuring strong assumptions are made regarding market needs, competition, and potential product success
Partner with cross-functional teams to create business cases for new products
Contribute to the preparation of pre-launch plans, ensuring a smooth transition from development to commercialization
Collaborate with internal teams, including Market Research, to design and implement primary market research studies that provide insights into disease areas, competitive markets, and the needs of physicians and patients
Support the NPP leader to lead the launch readiness activities from commercial perspective, ensuring that all functional areas are aligned and prepared for a successful product launch
Take ownership of the strategic planning process for the BU or TA, ensuring alignment with broader company goals
Play a key role in the brand development for critical launch brands for the responsible BU
Build and maintain strong relationships with global and local stakeholders, including the clinical project management team, BU marketing directors, and senior leadership
Work closely with global stakeholders to ensure the strategic direction for the BU or TA is aligned and integrated across different regions and departments, with a strong focus on anticipating and meeting key stakeholder needs

Skills

Market Research

Strategic Planning

Portfolio Evaluation

Business Case Development

Launch Readiness

Competitive Analysis

Forecasting

Cross-functional Collaboration

Primary Research

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free